Why a lab-made lung spray might calm down angry immune cells

Original Title

Regulation of human alveolar macrophage inflammatory cytokines by tyloxapol: a component of the synthetic surfactant Exosurf.

Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms

Summary

Scientists tested a lung spray called Exosurf and found one part, tyloxapol, made immune cells in a dish produce fewer inflammation signals when triggered by bacteria.

Sign up to see full results

Get access to research results, context, and detailed analysis.

Surprising Findings

Tyloxapol suppressed cytokine production at the mRNA level, suggesting it acts before the protein is even made.

Most people assume anti-inflammatory drugs work by blocking proteins after they’re made — but this suggests tyloxapol may stop the signal at the genetic level, which is a more powerful and less understood mechanism.

Practical Takeaways

Don’t try to self-administer tyloxapol — it’s not a supplement or OTC drug.

low confidence

Unlock Full Study Analysis

Sign up free to access quality scores, evidence strength analysis, and detailed methodology breakdowns.

3%
Lower QualityOverall Score

Publication

Journal

Clinical immunology and immunopathology

Year

1995

Authors

M. Thomassen, J. Antal, L. T. Divis, H. Wiedemann

29 citations
Analysis v1